ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETECTION OF A NOVEL 21-KDA PROTEIN ASSOCIATED WITH THE CLINICAL COURSE OF PATIENTS WITH UROGENITAL TUMORS
Channa Shalitin(Technion – Israel Institute of Technology), M LERNER(Rambam Health Care Campus), Ron Epelbaum(University of Bern), T. Mekori(Rambam Health Care Campus), Clari Valansi(Technion – Israel Institute of Technology), Ruth Segal(Rambam Health Care Campus), Boaz Moskovitz(Bnai Zion Medical Center)
Cited by 3
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279